MACK

Merrimack Pharmaceuticals, Inc.

Delisted

MACK was delisted on the 17th of May, 2024.

136 hedge funds and large institutions have $415M invested in Merrimack Pharmaceuticals, Inc. in 2016 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 40 increasing their positions, 42 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
136
Holders Change
+8
Holders Change %
+6.25%
% of All Funds
3.41%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
21
Increased
40
Reduced
42
Closed
13
Calls
$1.17M
Puts
$2.88M
Net Calls
-$1.72M
Net Calls Change
-$1.09M
Name Holding Trade Value Shares
Change
Shares
Change %
SSB
126
Sandy Spring Bank
Maryland
$4K
WA
127
WFG Advisors
Texas
$4K +$4K +127 New
NIT
128
NumerixS Investment Technologies
British Columbia, Canada
$3K +$3K +102 New
FANJ
129
Financial Architects (New Jersey)
New Jersey
$2K
HCM
130
Horrell Capital Management
Arkansas
$2K
TWA
131
TCI Wealth Advisors
Arizona
$2K
KF
132
Krilogy Financial
Missouri
$1K
JWA
133
JFS Wealth Advisors
Pennsylvania
$1K
US Bancorp
134
US Bancorp
Minnesota
$1K
PCM
135
Portolan Capital Management
Massachusetts
-$2.62M -52,389 Closed
TCM
136
Tekla Capital Management
Massachusetts
-$1.82M -36,351 Closed
Marshall Wace
137
Marshall Wace
United Kingdom
-$1.76M -35,288 Closed
Federated Hermes
138
Federated Hermes
Pennsylvania
-$635K -12,710 Closed
CB
139
Commerce Bank
Missouri
-$273K -5,465 Closed
LJAC
140
L.J. Altfest & Co
New York
-$1.51M -5,019 Closed
NEPWA
141
New England Private Wealth Advisors
Massachusetts
-$105K -2,125 Closed
Ameriprise
142
Ameriprise
Minnesota
-$69K -1,375 Closed
BFM
143
Boothbay Fund Management
New York
-$64K -1,271 Closed
FNYS
144
First New York Securities
New York
-$23.8K -477 Closed
CG
145
Cutler Group
California
-$17K -343 Closed
MRCM
146
M&R Capital Management
New Jersey
-$3K -64 Closed
RFA
147
Reilly Financial Advisors
California
-$1K -25 Closed